Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancer.
Bayoglu IV, Varol U, Yildiz I, Muslu U, Alacacioglu A, Kucukzeybek Y, Akyol M, Demir L, Dirican A, Cokmert S, Yildiz Y, Karabulut B, Uslu R, Tarhan MO.
Bayoglu IV, et al. Among authors: cokmert s.
Asian Pac J Cancer Prev. 2014;15(17):7119-23. doi: 10.7314/apjcp.2014.15.17.7119.
Asian Pac J Cancer Prev. 2014.
PMID: 25227800
Free article.